Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health


Author index

Page Path
HOME > Browse articles > Author index
Neda Parnianfard 1 Article
Severe complications of tramadol overdose in Iran
Paria Habibollahi, Alireza Garjani, Samad Shams Vahdati, Seyyed-Reza Sadat-Ebrahimi, Neda Parnianfard
Epidemiol Health. 2019;41:e2019026.   Published online June 16, 2019
  • 16,612 View
  • 272 Download
  • 10 Web of Science
  • 10 Crossref
AbstractAbstract PDF
Severe complications of tramadol overdose have been reported; however, few large-scale studies have investigated this issue. Therefore, this study aimed to explore the presentation and complications of tramadol overdose in patients admitted to an intoxication referral center in northwestern Iran.
Patients with tramadol overdose admitted to Sina Teaching Hospital in Tabriz, Iran during 2013-2017 were included. For each patient, the following data were collected: demographics, previous drug or medication overdose, whether the patient was in the process of quitting drug use, ingested dose of tramadol and co-ingestants, Glasgow Coma Scale (GCS) score, clinical symptoms at the time of admission, and admission characteristics. Serotonin toxicity was diagnosed in patients who fit the Hunter criteria. Multiple logistic regression was performed to identify variables associated with the incidence of severe complications of tramadol overdose.
In total, 512 cases of tramadol overdose were evaluated, of which 359 patients were included, with a median age of 41 years (range, 16-69) and a median tramadol dose of 1,500 mg (range, 500-4,000). The most frequent complications associated with tramadol overdose were hypertension (38.4%), tachycardia (24.8%), and seizure (14.5%). No serotonin toxicity was detected in patients. Having a GCS score <15, having taken a tramadol dose of >1,000 mg, being in the process of quitting drug use, being 30-49 years old, and male sex were significantly related to the incidence of severe complications of tramadol overdose.
Although seizure was prevalent among Iranian patients with tramadol poisoning, serotonin toxicity and cardiogenic shock were rare findings.


Citations to this article as recorded by  
  • Tramadol Abuse-associated Seizure: An Epidemiological and Electroencephalographic Study
    Farhad Iranmanesh, Hamide Arvan, Habibeh Ahmadipour, Faranak Gadari, Hussien Barzegar, Mahdiyeh Khazaneha
    International Journal of High Risk Behaviors and Addiction.2023;[Epub]     CrossRef
  • Clinical and Laboratory Factors Related to Seizure and Serotonin Toxicity in Tramadol Intoxication: An Egyptian Study
    Ahmed Amin Ali, Mahmoud Mohamed Abdeshafy, Khaled Abdelkawy, Ramy M. Elsabaa, Fawzy Elbarbry
    Clinical Drug Investigation.2023; 43(12): 963.     CrossRef
  • Lower uric acid and adequate hydration are associated with lower risk of febrile neutropenia following autologous bone marrow transplantation in patients with lymphoma
    Babak Nejati, Zohreh Kourehpaz, Roya Dolatkhah, Mojtaba Varshochi, Maryam Farmani, Alireza Parviz
    Journal of Medical Science.2023; 92(4): e836.     CrossRef
  • Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data
    Anne Roussin, Thomas Soeiro, Charlotte Fouque, Emilie Jouanjus, Elisabeth Frauger, Nathalie Fouilhé, Michel Mallaret, Joëlle Micallef, Maryse Lapeyre‐Mestre
    British Journal of Clinical Pharmacology.2022; 88(8): 3789.     CrossRef
  • Determination of Tramadol and Fluoxetine in Biological and Water Samples by Magnetic Dispersive Solid-Phase Microextraction (MDSPME) with Gas Chromatography – Mass Spectrometry (GC-MS)
    Banafsheh Sefaty, Mahboubeh Masrournia, Zarrin Es’haghi, Mohammad Reza Bozorgmehr
    Analytical Letters.2021; 54(5): 884.     CrossRef
  • Machine learning algorithms to predict seizure due to acute tramadol poisoning
    B Behnoush, E Bazmi, SH Nazari, S Khodakarim, MA Looha, H Soori
    Human & Experimental Toxicology.2021; 40(8): 1225.     CrossRef
  • Factors Associated with Tramadol Abuse: A Cross-Sectional Study Among Commercial Drivers and Assistants in the Accra Metropolitan Area of Ghana
    Mavis Danso, Francis Anto
    Drugs - Real World Outcomes.2021; 8(3): 337.     CrossRef
  • Evaluation of mitochondrial dysfunction due to oxidative stress in therapeutic, toxic and lethal concentrations of tramadol
    Leila Mohammadnejad, Kambiz Soltaninejad, Mohammad Seyedabadi, Seyed Khosro Ghasem Pouri, Mohammad Shokrzadeh, Hamidreza Mohammadi
    Toxicology Research.2021; 10(6): 1162.     CrossRef
  • Rapport de cas d’un choc cardiogénique et syndrome sérotoninergique sur une synergie entre tramadol et venlafaxine
    G. Barthélemy, D. Gusu, D. Glorieux
    Journal Européen des Urgences et de Réanimation.2021; 33(4): 201.     CrossRef
  • Drug utilization review of tramadol hydrochloride in a regional hospital in South Africa; findings and implications
    Akhona Fynn, Elvera Helberg, Brian Godman, Johanna C Meyer
    Hospital Practice.2020; 48(2): 92.     CrossRef

Epidemiol Health : Epidemiology and Health